[Congressional Record Volume 168, Number 158 (Thursday, September 29, 2022)]
[Senate]
[Pages S5660-S5661]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SA 6103. Ms. MURKOWSKI (for herself, Mrs. Feinstein, Mr. Sullivan,
and Ms. Hassan) submitted an amendment intended to be proposed to
amendment SA 5499 submitted by Mr. Reed (for himself and Mr. Inhofe)
and intended to be proposed to the bill H.R. 7900, to authorize
appropriations for fiscal year 2023 for military activities of the
Department of Defense, for military construction, and for defense
activities of the Department of Energy, to prescribe military personnel
strengths for such fiscal year, and for other purposes; which was
ordered to lie on the table; as follows:
At the appropriate place, insert the following:
SEC. ___. PROGRAMS TO ADDRESS SUBSTANCE USE DISORDER.
(a) Short Title.--This section may be cited as ``Bruce's
Law''.
(b) Awareness Campaigns.--
(1) Opioid program.--Section 102 of the Comprehensive
Addiction and Recovery Act of 2016 (Public Law 114-198) is
amended--
(A) in the section heading, by inserting ``relating to
opioids'' after ``campaigns''; and
(B) in subsection (c)--
(i) in paragraph (1), by inserting ``and'' after the
semicolon;
(ii) in paragraph (2)(B), by striking ``; and'' and
inserting a period; and
(iii) by striking paragraph (3).
(2) Additional campaign.--Title I of the Comprehensive
Addiction and Recovery Act of 2016 (Public Law 114-198) is
amended by inserting after section 102 the following:
``SEC. 102A. AWARENESS CAMPAIGN RELATED TO LETHALITY OF
FENTANYL AND FENTANYL-CONTAMINATED DRUGS.
``(a) In General.--The Secretary of Health and Human
Services, in coordination with the heads of other Federal
departments and agencies, shall, as appropriate, through a
public awareness campaign, advance the education and
awareness of the public (including school-aged children,
youth, parents, first responders, and providers) and other
appropriate entities regarding the risk of counterfeit drugs
being contaminated with fentanyl or other synthetic opioids
and the lethality and other dangers of synthetic opioids.
``(b) Topics.--The education and awareness campaigns under
subsection (a) shall address--
``(1) the dangers of using drugs which may be contaminated
with fentanyl or other synthetic opioids;
``(2) the prevention of substance use disorder and use of
drugs other than as prescribed, including through safe
disposal of prescription medications and other safety
precautions; and
``(3) the detection of early warning signs of substance use
disorder and addiction in school-aged children and youth.
``(c) Other Requirements.--The education and awareness
campaigns under subsection (a) shall, as appropriate, take
into account any association between the use of prescription
drugs other than as prescribed and the use of drugs that can
be contaminated by fentanyl or other synthetic opioids,
including heroin.
``(d) Drug Defined.--In this section, the term `drug' means
an illicit drug, such as marijuana, hashish, cocaine
(including crack cocaine), inhalants, hallucinogens, heroin,
a synthetic opioid, methamphetamine or other stimulant, a
counterfeit prescription drug, or a prescription drug that is
sold illegally.
``(e) Authorization of Appropriations.--There are
authorized to be appropriated for fiscal years 2023 through
2027 such sums as may be necessary to carry out this
section.''.
(c) Federal Interagency Work Group on Fentanyl
Contamination of Illegal Drugs.--Title I of the Comprehensive
Addiction and Recovery Act of 2016 (Public Law 114-198), as
amended by subsection (b)(2), is further amended by inserting
after section 102A the following:
``SEC. 102B. FEDERAL INTERAGENCY WORK GROUP ON FENTANYL
CONTAMINATION OF ILLEGAL DRUGS.
``(a) Establishment.--The Secretary of Health and Human
Services (referred to in this section as the `Secretary')
shall establish the Federal Interagency Work Group on
Fentanyl Contamination of Illegal Drugs (referred to in this
section as the `Work Group').
``(b) Membership; Consultation.--
``(1) Composition.--Not later than 120 days after the date
of enactment of Bruce's Law, the heads of the Office of
National Drug Control Policy, the Substance Abuse and Mental
Health Services Administration, the Administration for
Children and Families, the Centers for Disease Control and
Prevention, the Department of Justice, the Drug Enforcement
Administration, the Department of State, the Department of
Education, and other Federal agencies (as determined by the
Secretary) shall designate representatives of the respective
agency or office to the Work Group.
``(2) Consultation.--The Work Group shall consult with--
``(A) experts at the State, Tribal, and local levels with
relevant backgrounds in reducing, preventing, and responding
to drug overdose by fentanyl contamination of illegal drugs;
``(B) individuals in recovery from misuse of fentanyl or
other synthetic opioids;
``(C) family members of adults who have overdosed by
fentanyl-contaminated illegal drugs;
``(D) family members of school-aged children and youth who
have overdosed by fentanyl-contaminated illegal drugs;
``(E) researchers and other experts in the design and
implementation of effective drug-related messaging and
prevention campaigns; and
``(F) technology companies.
``(c) Duties.--The Work Group shall--
``(1) examine all Federal efforts directed towards reducing
and preventing drug overdose by fentanyl- or other synthetic
opioid-contaminated illegal drugs;
``(2) identify strategies, resources, and supports to
improve State, Tribal, and local responses to overdose by
fentanyl- or other synthetic opioid-contaminated illegal
drugs;
``(3) make recommendations to Congress for improving
Federal programs and efforts and coordination across such
programs and efforts to reduce and prevent drug overdose by
fentanyl- or other synthetic opioid-contaminated illegal
drugs; and
``(4) make recommendations for educating youth on the
dangers of drugs contaminated by fentanyl or other synthetic
opioids.
``(d) Annual Report to Secretary.--The Work Group shall
annually prepare and submit to the Secretary, the Committee
on Health, Education, Labor, and Pensions of the Senate, and
the Committee on Education and Labor and the Committee on
Energy and Commerce of the House of Representatives, a report
on the activities carried out by the Work Group under
subsection (c), including recommendations to reduce and
prevent drug overdose by fentanyl or other synthetic opioid
contamination of illegal drugs, in all populations, and
specifically among youth at risk for substance use disorder
and use of drugs other than as prescribed.''.
(d) Community-based Coalition Enhancement Grants to Address
Local Drug Crises.--Section 103(i) of the Comprehensive
Addiction and Recovery Act of 2016 (21 U.S.C. 1536(i)) is
amended by striking ``2017 through 2021'' and inserting
``2023 through 2027''.
(e) Community-based Coalition Enhancement Grants to Educate
Youth on the Risks of Drugs Contaminated With Fentanyl or
Other Synthetic Opioids.--Title I of the Comprehensive
Addiction and Recovery Act of 2016 (Public Law 114-198) is
amended by inserting after section 103 the following:
``SEC. 103A. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO
EDUCATE YOUTH ON THE RISKS OF DRUGS
CONTAMINATED WITH FENTANYL OR OTHER SYNTHETIC
OPIOIDS.
``(a) Program Authorized.--The Director of the Office of
National Drug Control Policy (referred to in this section as
the `Director'), in coordination with the Director of the
Centers for Disease Control and Prevention, may make grants
to eligible entities to implement education of the public on
the dangers of contamination of drugs with fentanyl or other
synthetic opioids.
``(b) Application.--
``(1) In general.--An eligible entity seeking a grant under
this section shall submit an application to the Director at
such time, in such manner, and accompanied by such
information as the Director may require.
``(2) Criteria.--As part of an application for a grant
under this section, the Director shall require an eligible
entity to submit a detailed, comprehensive, multisector plan
for addressing the implementation of an evidence-based public
education campaign on the dangers of drugs contaminated with
fentanyl or other synthetic opioids, with a specific
consideration given to education focused on youth at
increased risk for developing a substance use disorder.
``(3) Eligible entities.--For purposes of this section, the
term `eligible entity'--
``(A) means an entity that has documented, using local
data, rates of drug overdose related to fentanyl or other
synthetic opioids at levels that are significant, as
determined by the Director; and
``(B) may include an entity that has received a grant under
the Drug-Free Communities Act of 1997.
``(c) Use of Funds.--An eligible entity shall use a grant
received under this section--
``(1) for programs designed to implement comprehensive
community-wide prevention strategies to address the dangers
of drugs contaminated with fentanyl or other synthetic
opioids, in the area served by the eligible entity, in
accordance with the plan submitted under subsection (b)(2);
[[Page S5661]]
``(2) to obtain specialized training and technical
assistance from the organization funded under section 4 of
Public Law 107-82 (21 U.S.C. 1521 note); and
``(3) for programs designed to implement comprehensive
community-wide strategies to address the dangers of drugs
contaminated with fentanyl or other synthetic opioids in the
community.
``(d) Supplement Not Supplant.--An eligible entity shall
use Federal funds received under this section only to
supplement the funds that would, in the absence of those
Federal funds, be made available from other Federal and non-
Federal sources for the activities described in this section,
and not to supplant those funds.
``(e) Evaluation.--A grant under this section shall be
subject to the same evaluation requirements and procedures as
the evaluation requirements and procedures imposed on the
recipient of a grant under the Drug-Free Communities Act of
1997, and shall also include an evaluation of the
effectiveness at reducing the use of illicit fentanyl or
other synthetic opioids.
``(f) Limitation on Administrative Expenses.--Not more than
12 percent of the amounts made available to carry out this
section for a fiscal year may be used to pay for
administrative expenses.
``(g) Delegation Authority.--The Director may enter into an
interagency agreement with the Director of the Centers for
Disease Control and Prevention to delegate authority for the
execution of grants and for such other activities, as the
Director determines necessary to carry out this section.
``(h) Definition.--In this section, the term `drug' means
an illicit drug, such as marijuana, hashish, cocaine
(including crack cocaine), inhalants, hallucinogens, heroin,
a synthetic opioid, methamphetamine or other stimulant, a
counterfeit prescription drug, or a prescription drug that is
sold illegally.
``(i) Authorization of Appropriations.--For the purpose of
carrying out this section, there are authorized to be
appropriated such sums as may be necessary for each of fiscal
years 2023 through 2027.''.
______